Experiment: 7R7Q

SOLID-STATE NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D CORD 50 ms	400 uM [U-100% 13C; U-100% 15N] HIV-1 CACTD-SP1, 400 uM IP6	Protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 850
2	2D CORD 100 ms	400 uM [U-100% 13C; U-100% 15N] HIV-1 CACTD-SP1, 400 uM IP6	Protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 850
3	2D NCACX 50 ms	400 uM [U-100% 13C; U-100% 15N] HIV-1 CACTD-SP1, 400 uM IP6	Protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 850
4	2D NCACX 50 ms	400 uM [U-100% 13C; U-100% 15N] HIV-1 CACTD-SP1, 400 uM IP6	Protein buffer	250 mM	8	1 atm	263.15	Bruker AVANCE III 850
5	3D NCOCX 25 ms	400 uM [U-100% 13C; U-100% 15N] HIV-1 CACTD-SP1, 400 uM IP6	Protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 850
6	2D CORD 25 ms	400 uM [U-100% 13C; U-100% 15N] HIV-1 CACTD-SP1, 400 uM IP6	Protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 600
7	2D CORD 50 ms	400 uM [U-100% 13C; U-100% 15N] HIV-1 CACTD-SP1, 400 uM IP6	Protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 600
8	2D NCACX 25 ms	400 uM [U-100% 13C; U-100% 15N] HIV-1 CACTD-SP1, 400 uM IP6	Protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 600
9	2D NCOCX 25 ms	400 uM [U-100% 13C; U-100% 15N] HIV-1 CACTD-SP1, 400 uM IP6	Protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 600
10	3D NCACX 25 ms	400 uM [U-100% 13C; U-100% 15N] HIV-1 CACTD-SP1, 400 uM IP6	Protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 600
11	2D NCACX 25 ms	400 uM [U-100% 13C; U-100% 15N] HIV-1 CACTD-SP1, 400 uM IP6	Protein buffer	250 mM	8	1 atm	194.15	Bruker AVANCE III 750
12	2D NCOCX 25 ms	400 uM [U-100% 13C; U-100% 15N] HIV-1 CACTD-SP1, 400 uM IP6	Protein buffer	250 mM	8	1 atm	194.15	Bruker AVANCE III 750
13	2D CORD 50 ms	400 uM [U-100% 13C; U-100% 15N; 99.9%-2H] HIV-1 CACTD-SP1, 400 uM IP6	Protein buffer	250 mM	8	1 atm	268.15	Bruker AVANCE III 850
14	2D HC CP HETCOR	400 uM [U-100% 13C; U-100% 15N; 99.9%-2H] HIV-1 CACTD-SP1, 400 uM IP6	Protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 850
15	2D doubleREDOR HETCOR	400 uM [U-100% 13C; U-100% 15N; 99.9%-2H] HIV-1 CACTD-SP1, 400 uM IP6	Protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 850
16	1D 31P direct polarization	400 uM [U-100% 13C; U-100% 15N; 99.9%-2H] HIV-1 CACTD-SP1, 400 uM IP6	Protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 850
17	1D 31P cross polarization	400 uM [U-100% 13C; U-100% 15N; 99.9%-2H] HIV-1 CACTD-SP1, 400 uM IP6	Protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 850
18	1D doubleREDOR	400 uM [U-100% 13C; U-100% 15N; 99.9%-2H] HIV-1 CACTD-SP1, 400 uM IP6	Protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 850
19	2D hNH HETCOR	400 uM [U-100% 13C; U-100% 15N; 99.9%-2H] HIV-1 CACTD-SP1, 400 uM IP6 S2	Protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 850
20	2D HC CP HETCOR	400 uM [U-100% 13C; U-100% 15N; 99.9%-2H] HIV-1 CACTD-SP1, 400 uM IP6 S2	Protein buffer	250 mM	8	1 atm	277.15	Bruker AVANCE III 850

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	850
2	Bruker	AVANCE III	600
3	Bruker	AVANCE III	750

NMR Refinement
Method	Details	Software
simulated annealing		X-PLOR NIH

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	5
Representative Model	1 (lowest energy)

Additional NMR Experimental Information
Details	magic angle spinning

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	TopSpin		Bruker Biospin
2	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
3	chemical shift assignment	NMRFAM-SPARKY	3.115	Lee, Tonellli, Markley
4	chemical shift assignment	CcpNmr Analysis	2.4	CCPN
5	data analysis	NMRFAM-SPARKY	3.115	Lee, Tonellli and Markley
6	structure calculation	TALOS-N		Shen and Bax
7	structure calculation	X-PLOR NIH	2.53	Schwieters, Kuszewski, Tjandra and Clore
8	refinement	X-PLOR NIH	2.53	Schwieters, Kuszewski, Tjandra and Clore

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.

Prepare Data

Validate Data

Deposit Data

Help and Resources

7R7Q

Immature HIV-1 CACTD-SP1 lattice with Inositol hexakisphosphate (IP6)